They can potentially be used to develop passive antibody therapy against influenza virus transmission.

Therefore, rather than being a passive antibody therapy, Racotumomab acts as a therapeutic vaccine.

People who have had more than 25% of their bone marrow replaced or been treated with radiation should not have this monoclonal antibody therapy.

But such antibody therapy, known as passive immunization, is also risky.

"We are true believers in antibody therapy," Dr. Scheinberg said.

A clinical trial of radiolabeled monoclonal antibody therapy.

The addition of antibody therapy has raised survival rates for high-risk disease significantly.

The randomization was stopped so all patients enrolling on the trial will receive the antibody therapy.

Medical activities include the construction of Positron emission tomography, nuclide based antibody therapy, and scintigraphy units.

Monoclonal antibody therapy uses antibodies made in the laboratory, from a single type of immune system cell.